{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:48:26Z","timestamp":1792205306847,"version":"4.4.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,14]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>A \u201crestrictive\u201d red blood cell transfusion threshold, a hemoglobin concentration &amp;lt;7 to 8 g\/dL, has long been recommended for most hospitalized patients including anemic patients with stable cardiovascular disease (CVD). Although no threshold recommendation is given for acute coronary syndromes (ACSs), recent evidence suggests that \u201cliberal\u201d rather than \u201crestrictive\u201d transfusion strategies are associated with significantly improved safety for\u00a0hospitalized patients with stable CVD and\/or ACS. This finding suggests that previously available data were misinterpreted. Conclusions drawn from earlier transfusion trigger trials have been confounded by unintentional trial design and analysis flaws that have contributed to erroneous recommendations regarding the safety of a restrictive threshold. Subsequently, these conclusions have been incorporated into widely accepted guidelines and clinical practice. Management with a restrictive vs liberal transfusion strategy (&amp;lt;10 g\/dL) increases the risk of new-onset ACS in patients with CVD by \u223c2%. We estimate that since 2019, using hospital databases and a recent meta-analysis, this practice may have resulted in \u223c700 excess ACS events per year in orthopedic surgical patients. Given these findings, transfusion practices in other clinical conditions, particularly those derived from similar transfusion trigger trials, should be questioned. Restrictive and liberal transfusion policies merit a general reconsideration. Rather than a single numerical transfusion trigger, transfusion therapy should be personalized. Consideration of an individual patient\u2019s age, clinical status, and comorbidities is integral to transfusing. To avoid making similar errors, future trials of transfusion therapy should determine common practices before study inception and incorporate them as a usual-care \u201ccontrol\u201d comparator arm into the trial design. Such studies should more reliably improve current transfusion practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024025927","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T20:19:32Z","timestamp":1726690772000},"page":"2075-2082","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Hemoglobin-based transfusion strategies for cardiovascular and other diseases: restrictive, liberal, or neither?"],"prefix":"10.1182","volume":"144","author":[{"given":"Charles","family":"Natanson","sequence":"first","affiliation":[{"name":"1Critical Care Medicine Department, Clinical Center, and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willard N.","family":"Applefeld","sequence":"additional","affiliation":[{"name":"2Division of Cardiology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey G.","family":"Klein","sequence":"additional","affiliation":[{"name":"3Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"16","key":"2024111416210612800_bib1","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"issue":"9034","key":"2024111416210612800_bib2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(96)04330-9","article-title":"Effect of anaemia and cardiovascular disease on surgical mortality and morbidity","volume":"348","author":"Carson","year":"1996","journal-title":"Lancet"},{"issue":"17","key":"2024111416210612800_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa010615","article-title":"Blood transfusion in elderly patients with acute myocardial infarction","volume":"345","author":"Wu","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2024111416210612800_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1423-0410.2009.01223.x","article-title":"Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger","volume":"98","author":"Wang","year":"2010","journal-title":"Vox Sang"},{"issue":"5","key":"2024111416210612800_bib5","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.155.5.9154866","article-title":"Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group","volume":"155","author":"H\u00e9bert","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2024111416210612800_bib6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2005.06.072","article-title":"The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative","volume":"46","author":"Yang","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"2024111416210612800_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00003246-200102000-00001","article-title":"Is a low transfusion threshold safe in critically ill patients with cardiovascular disease?","volume":"29","author":"H\u00e9bert","year":"2001","journal-title":"Crit Care Med"},{"issue":"6","key":"2024111416210612800_bib8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ahj.2008.01.009","article-title":"Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes","volume":"155","author":"Alexander","year":"2008","journal-title":"Am Heart J"},{"issue":"1","key":"2024111416210612800_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2141.2001.02701.x","article-title":"Guidelines for the clinical use of red cell transfusions","volume":"113","author":"Murphy","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"2024111416210612800_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","article-title":"Red blood cell transfusion: a clinical practice guideline from the AABB","volume":"157","author":"Carson","year":"2012","journal-title":"Ann Intern Med"},{"issue":"12","key":"2024111416210612800_bib11","first-page":"CD002042","article-title":"Transfusion thresholds for guiding red blood cell transfusion","volume":"12","author":"Carson","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2024111416210612800_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jama.2021.0135","article-title":"Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial","volume":"325","author":"Ducrocq","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"2024111416210612800_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCULATIONAHA.121.057909","article-title":"One-year major cardiovascular events after restrictive versus liberal blood transfusion strategy in patients with acute myocardial infarction and anemia: the REALITY randomized trial","volume":"145","author":"Gonzalez-Juanatey","year":"2022","journal-title":"Circulation"},{"issue":"26","key":"2024111416210612800_bib14","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1056\/NEJMoa2307983","article-title":"Restrictive or liberal transfusion strategy in myocardial infarction and anemia","volume":"389","author":"Carson","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2024111416210612800_bib15","doi-asserted-by":"crossref","first-page":"e010957","DOI":"10.1161\/CIRCOUTCOMES.124.010957","article-title":"Risks of restrictive versus liberal red blood cell transfusion strategies in patients with cardiovascular disease: an updated meta-analysis","volume":"17","author":"Applefeld","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2024111416210612800_bib16","unstructured":"Premier Healthcare Database White Paper: Data that informs and performs, September 7, 2020. Premier Applied Sciences\u00ae. Premier Inc. Accessed 20 April 2024. https:\/\/offers.premierinc.com\/rs\/381-NBB-525\/images\/PremierHealthcareDatabaseWhitepaper.pdf."},{"issue":"6","key":"2024111416210612800_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A\u00a0multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group","volume":"340","author":"H\u00e9bert","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"2024111416210612800_bib18","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1001\/jama.1988.03410180108040","article-title":"Consensus conference: Perioperative red blood cell transfusion","volume":"260","year":"1988","journal-title":"JAMA"},{"issue":"5","key":"2024111416210612800_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7326\/0003-4819-116-5-403","article-title":"Practice strategies for elective red blood cell transfusion. American College of Physicians","volume":"116","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"2024111416210612800_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00003246-199803000-00019","article-title":"A\u00a0Canadian survey of transfusion practices in critically ill patients","volume":"26","author":"Hebert","year":"1998","journal-title":"Crit Care Med"},{"issue":"6","key":"2024111416210612800_bib21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/01.CCM.0000266584.40715.A6","article-title":"Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols","volume":"35","author":"Deans","year":"2007","journal-title":"Crit Care Med"},{"issue":"1","key":"2024111416210612800_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/15265161.2019.1687777","article-title":"Misrepresenting \u201cusual care\u201d in research: an ethical and scientific error","volume":"20","author":"Macklin","year":"2020","journal-title":"Am J Bioeth"},{"issue":"1","key":"2024111416210612800_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/17407745231195094","article-title":"Controls, comparator arms, and designs for critical care comparative effectiveness research: it\u2019s complicated","volume":"21","author":"Ford","year":"2024","journal-title":"Clin Trials"},{"issue":"2","key":"2024111416210612800_bib24","first-page":"150","article-title":"Modeling current practices in critical care comparative effectiveness research","volume":"24","author":"Applefeld","year":"2022","journal-title":"Crit Care Resusc"},{"issue":"5","key":"2024111416210612800_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/tme.12535","article-title":"Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysis","volume":"28","author":"Cort\u00e9s-Puch","year":"2018","journal-title":"Transfus Med"},{"issue":"26","key":"2024111416210612800_bib26","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1012452","article-title":"Liberal or restrictive transfusion in high-risk patients after hip surgery","volume":"365","author":"Carson","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"2024111416210612800_bib27","first-page":"1011","article-title":"Anesthesia in cases of poor risk. Some suggestions for decreasing the risk","volume":"74","author":"Adams","year":"1942","journal-title":"Surg Gynecol Obstet"},{"issue":"3","key":"2024111416210612800_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/17453674.2015.1006980","article-title":"Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial","volume":"86","author":"Gregersen","year":"2015","journal-title":"Acta Orthop"},{"issue":"3","key":"2024111416210612800_bib29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbmt.2012.12.002","article-title":"Excess of veno-occlusive disease in a randomized trial on a higher trigger for red cell transfusion after bone marrow transplantation: a Canadian blood and marrow transplant group trial","volume":"19","author":"Robitaille","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2024111416210612800_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1537-2995.2007.01485.x","article-title":"A\u00a0multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation","volume":"48","author":"Webert","year":"2008","journal-title":"Transfusion"},{"issue":"3","key":"2024111416210612800_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/tme.12439","article-title":"Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy","volume":"28","author":"Yakymenko","year":"2018","journal-title":"Transfus Med"},{"issue":"1","key":"2024111416210612800_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2010.09.024","article-title":"The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy\u2013results from the randomized DAHANCA 5 study","volume":"98","author":"Hoff","year":"2011","journal-title":"Radiother Oncol"},{"issue":"2","key":"2024111416210612800_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.21037\/jtd.2018.01.78","article-title":"Teaching an old dog new TRICS: re-evaluating transfusion triggers in high-risk cardiac surgery","volume":"10","author":"Chow","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"2024111416210612800_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1537-2995.1980.20280169958.x","article-title":"An analysis of blood transfusion of surgical patients by sex: a question for the transfusion trigger","volume":"20","author":"Friedman","year":"1980","journal-title":"Transfusion"},{"issue":"12","key":"2024111416210612800_bib35","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.288.12.1499","article-title":"Anemia and blood transfusion in critically ill patients","volume":"288","author":"Vincent","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"2024111416210612800_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.CCM.0000104112.34142.79","article-title":"The CRIT study: anemia and blood transfusion in the critically ill\u2013current clinical practice in the United States","volume":"32","author":"Corwin","year":"2004","journal-title":"Crit Care Med"},{"issue":"10","key":"2024111416210612800_bib37","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1537-2995.2010.02697.x","article-title":"Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study","volume":"50","author":"Vuille-Lessard","year":"2010","journal-title":"Transfusion"},{"issue":"19","key":"2024111416210612800_bib38","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.2023.12914","article-title":"Red blood cell transfusion: 2023 AABB International Guidelines","volume":"330","author":"Carson","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"2024111416210612800_bib39","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.2019.0554","article-title":"Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference; ICC PBM Frankfurt\u00a02018 Group","volume":"12","author":"Mueller","year":"2019","journal-title":"JAMA"},{"key":"2024111416210612800_bib40","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2404360","article-title":"Liberal or restrictive transfusion strategy in patients with traumatic brain injury","author":"Turgeon","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024111416210612800_bib41","first-page":"CD011305","article-title":"Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support","volume":"5","author":"Radford","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"2024111416210612800_bib42","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.2015.10890","article-title":"Red blood cell transfusion: precision vs imprecision medicine","volume":"314","author":"Klein","year":"2015","journal-title":"JAMA"},{"issue":"19","key":"2024111416210612800_bib43","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1001\/jama.2023.16134","article-title":"Precision in transfusion medicine","volume":"330","author":"Neal","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"2024111416210612800_bib44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MOH.0000000000000536","article-title":"Banking with precision: transfusion medicine as a potential universal application in clinical genomics","volume":"26","author":"Montemayor","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2024111416210612800_bib45","doi-asserted-by":"crossref","first-page":"e152598","DOI":"10.1172\/jci.insight.152598","article-title":"Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness","volume":"7","author":"Roubinian","year":"2022","journal-title":"JCI Insight"},{"issue":"7","key":"2024111416210612800_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamasurg.2023.0819","article-title":"Association of trauma molecular endotypes with differential response to transfusion resuscitation strategies","volume":"158","author":"Thau","year":"2023","journal-title":"JAMA Surg"},{"issue":"12","key":"2024111416210612800_bib47","doi-asserted-by":"crossref","first-page":"100478","DOI":"10.1016\/j.xcrm.2021.100478","article-title":"Multi-omic analysis in injured humans: patterns align with outcomes and treatment responses","volume":"2","author":"Wu","year":"2021","journal-title":"Cell Rep Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/20\/2075\/2313525\/blood_bld-2024-025927-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/20\/2075\/2313525\/blood_bld-2024-025927-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:21:53Z","timestamp":1731601313000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/20\/2075\/517880\/Hemoglobin-based-transfusion-strategies-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":47,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024025927","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}